101 related articles for article (PubMed ID: 24090643)
1. Treatment implications for men when switching from male to female bone mineral density reference data: the Manitoba Bone Density Program.
Leslie WD; Majumdar SR
J Clin Densitom; 2013; 16(4):537-42. PubMed ID: 24090643
[TBL] [Abstract][Full Text] [Related]
2. Selection of women aged 50-64 yr for bone density measurement.
Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
J Clin Densitom; 2013; 16(4):570-8. PubMed ID: 23452870
[TBL] [Abstract][Full Text] [Related]
3. Of fracture thresholds and bone mineral density reference data: does one size really fit all?
Majumdar SR; Leslie WD
J Clin Densitom; 2013; 16(4):543-8. PubMed ID: 24094358
[TBL] [Abstract][Full Text] [Related]
4. Fracture risk assessment without bone density measurement in routine clinical practice.
Leslie WD; Morin S; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
Osteoporos Int; 2012 Jan; 23(1):75-85. PubMed ID: 21850546
[TBL] [Abstract][Full Text] [Related]
5. Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program.
Leslie WD; Aubry-Rozier B; Lix LM; Morin SN; Majumdar SR; Hans D
Bone; 2014 Oct; 67():10-4. PubMed ID: 24998455
[TBL] [Abstract][Full Text] [Related]
6. Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study.
Ensrud KE; Taylor BC; Peters KW; Gourlay ML; Donaldson MG; Leslie WD; Blackwell TL; Fink HA; Orwoll ES; Schousboe J;
BMJ; 2014 Jul; 349():g4120. PubMed ID: 24994809
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry.
Cadarette SM; Jaglal SB; Murray TM; McIsaac WJ; Joseph L; Brown JP;
JAMA; 2001 Jul; 286(1):57-63. PubMed ID: 11434827
[TBL] [Abstract][Full Text] [Related]
8. Indications of DXA in women younger than 65 yr and men younger than 70 yr: the 2013 Official Positions.
Malabanan AO; Rosen HN; Vokes TJ; Deal CL; Alele JD; Olenginski TP; Schousboe JT
J Clin Densitom; 2013; 16(4):467-71. PubMed ID: 24055260
[TBL] [Abstract][Full Text] [Related]
9. [FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population].
Azagra R; Roca G; Martín-Sánchez JC; Casado E; Encabo G; Zwart M; Aguyé A; Díez-Pérez A;
Med Clin (Barc); 2015 Jan; 144(1):1-8. PubMed ID: 24461732
[TBL] [Abstract][Full Text] [Related]
10. Fracture burden in relation to low bone mineral density and FRAX(®) probability.
Leslie WD; Morin S
J Clin Densitom; 2011; 14(3):279-85. PubMed ID: 21723761
[TBL] [Abstract][Full Text] [Related]
11. [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture].
Naranjo A; Ojeda-Bruno S; Francisco-Hernández F; Erausquin C; Rúa-Figueroa I; Rodríguez-Lozano C
Med Clin (Barc); 2011 Mar; 136(7):290-2. PubMed ID: 21185575
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
[TBL] [Abstract][Full Text] [Related]
13. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.
Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW
Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992
[TBL] [Abstract][Full Text] [Related]
14. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study.
Berry SD; Kiel DP; Donaldson MG; Cummings SR; Kanis JA; Johansson H; Samelson EJ
Osteoporos Int; 2010 Jan; 21(1):53-60. PubMed ID: 19937426
[TBL] [Abstract][Full Text] [Related]
15. Use of FRAX as a determinant for risk-based osteoporosis screening may decrease unnecessary testing while improving the odds of identifying treatment candidates.
Edwards FD; Grover ML; Cook CB; Chang YH
Womens Health Issues; 2014; 24(6):629-34. PubMed ID: 25128036
[TBL] [Abstract][Full Text] [Related]
16. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
17. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns.
Dawson-Hughes B; Looker AC; Tosteson AN; Johansson H; Kanis JA; Melton LJ
Osteoporos Int; 2010 Jan; 21(1):41-52. PubMed ID: 19705046
[TBL] [Abstract][Full Text] [Related]
18. Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study.
Hans D; Goertzen AL; Krieg MA; Leslie WD
J Bone Miner Res; 2011 Nov; 26(11):2762-9. PubMed ID: 21887701
[TBL] [Abstract][Full Text] [Related]
19. Impact on the population of different bone mineral density testing criteria and appropriateness of densitometries in the ESOSVAL cohort, Spain.
Hurtado I; Sanfélix-Gimeno G; Baixauli-Pérez C; Peiró S; Sanfélix-Genovés J
J Clin Endocrinol Metab; 2014 Jan; 99(1):142-50. PubMed ID: 24384018
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy.
James H; Aleksic I; Bienz MN; Pieczonka C; Iannotta P; Albala D; Mariados N; Mouraviev V; Saad F
Urology; 2014 Jul; 84(1):164-8. PubMed ID: 24976229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
